Cargando…
PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA.
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431398/ http://dx.doi.org/10.1097/01.HS9.0000851080.24323.d4 |
_version_ | 1784780044417105920 |
---|---|
author | Ben Sghaier, R. kmira, Z. bouslama, E. zaier, M. |
author_facet | Ben Sghaier, R. kmira, Z. bouslama, E. zaier, M. |
author_sort | Ben Sghaier, R. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9431398 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-94313982022-08-31 PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. Ben Sghaier, R. kmira, Z. bouslama, E. zaier, M. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431398/ http://dx.doi.org/10.1097/01.HS9.0000851080.24323.d4 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Ben Sghaier, R. kmira, Z. bouslama, E. zaier, M. PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. |
title | PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. |
title_full | PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. |
title_fullStr | PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. |
title_full_unstemmed | PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. |
title_short | PB2062: EPIDEMIOLOGICAL, CLINICAL AND THERAPEUTIC FEATURES OF REFRACTORY HODGKIN’S LYMPHOMA. |
title_sort | pb2062: epidemiological, clinical and therapeutic features of refractory hodgkin’s lymphoma. |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431398/ http://dx.doi.org/10.1097/01.HS9.0000851080.24323.d4 |
work_keys_str_mv | AT bensghaierr pb2062epidemiologicalclinicalandtherapeuticfeaturesofrefractoryhodgkinslymphoma AT kmiraz pb2062epidemiologicalclinicalandtherapeuticfeaturesofrefractoryhodgkinslymphoma AT bouslamae pb2062epidemiologicalclinicalandtherapeuticfeaturesofrefractoryhodgkinslymphoma AT zaierm pb2062epidemiologicalclinicalandtherapeuticfeaturesofrefractoryhodgkinslymphoma |